Entero Healthcare Solutions Limited’s Board of Directors met on February 12, 2026, to approve the Unaudited Financial Results for Q3 FY2026 (quarter and nine months ended December 31, 2025). The Board also approved the grant of 5,000 fresh Employee Stock Options under the existing 2023 plan. Importantly, the Board decided to cancel the previously proposed acquisition of Khera Medisolutions Private Limited and AV Medisolutions Private Limited due to commercial reasons.
Outcome of Board Meeting on February 12, 2026
The Board of Directors of Entero Healthcare Solutions Limited convened on February 12, 2026, from 03:00 P.M. to 05:30 P.M. (IST), and approved key corporate actions and financial outcomes, which are detailed below.
Unaudited Financial Results Approval
The Board formally approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2025. These results were accompanied by the Limited Review Reports from the Statutory Auditors, which carried an unmodified opinion.
Standalone Highlights (Nine Months Ended Dec 31, 2025)
Key figures from the Unaudited Standalone Results (Rs. in Millions):
- Total Income: 3,430.76 (compared to 4,248.63 for the nine months ended Dec 31, 2024).
- Profit Before Tax: 181.48.
- Profit for the period/year: 134.59 (compared to 469.87 for the nine months ended Dec 31, 2024).
Consolidated Highlights (Nine Months Ended Dec 31, 2025)
Key figures from the Unaudited Consolidated Results (Rs. in Millions):
- Total Income: 46,965.14 (compared to 37,889.37 for the nine months ended Dec 31, 2024).
- Profit Before Tax: 1,213.89 (compared to 1,015.14 for the nine months ended Dec 31, 2024).
- Profit for the period/year: 1,007.12 (compared to 760.11 for the nine months ended Dec 31, 2024).
Employee Stock Option Grant
The Board noted the approval from the Nomination & Remuneration Committee for the grant of fresh 5,000 (Five Thousand only) Employee Stock Options. These options are issued under the existing “Entero Employee Stock Option Plan 2023”.
Cancellation of Acquisitions
A significant decision involved the cancellation of the proposed acquisition of two entities: Khera Medisolutions Private Limited and AV Medisolutions Private Limited. These potential acquisitions were initially communicated via letters dated May 27, 2025, and August 08, 2025, but the cancellation is due to prevailing commercial reasons.
Regulatory Filing Note (UDIN)
The company also issued a supplementary note informing exchanges that, due to scheduled maintenance on the UDIN portal, the results were filed for the quarter ended December 31, 2025, without mentioning the UDIN. The UDIN will be updated once it is successfully generated.
Source: BSE
